James Canterbury is a Principal working with EY’s Risk Advisory practice where he is part of the global blockchain team, focused on Life Sciences product quality and compliance. He helps his clients understand new technologies and how they might be applied to solve real-world problems. Specifically for blockchain he works to educate clients on the new technology and designs solutions to capitalize on the benefits of a blockchain network when designing efficient, transparent, and trusted solutions. He has 15 years of experience helping biopharma companies find innovative answers to the challenges created by operating in a highly regulated industry. Before blockchain, he primarily managed projects that span from interpreting FDA regulations to privacy & security to financial controls. James holds a BS in Industrial Engineering from Penn State University and is a Certified Information Systems Auditor. He currently sits on the board of the NJ chapter of ISPE, is the Co-Chair for the Global GAMP Steering Committee, and leads the GAMP Blockchain special interest group.